Your browser doesn't support javascript.
loading
[Progress in research of prophylactic therapy in contacts of rifampicin-resistant tuberculosis patients].
Wang, Z; Wang, W J; Ding, X Y; Lu, P; Zhu, L M; Liu, Q; Lu, W.
Afiliação
  • Wang Z; Department of Chronic Communicable Disease, Center for Disease Control and Prevention of Jiangsu Province, Nanjing 210009, China Department of Epidemiology for School of Public Health, Nanjing Medical University, Nanjing 211166, China.
  • Wang WJ; Department of Chronic Communicable Disease, Center for Disease Control and Prevention of Jiangsu Province, Nanjing 210009, China Department of Epidemiology for School of Public Health, Nanjing Medical University, Nanjing 211166, China.
  • Ding XY; Department of Chronic Communicable Disease, Center for Disease Control and Prevention of Jiangsu Province, Nanjing 210009, China.
  • Lu P; Department of Chronic Communicable Disease, Center for Disease Control and Prevention of Jiangsu Province, Nanjing 210009, China.
  • Zhu LM; Department of Chronic Communicable Disease, Center for Disease Control and Prevention of Jiangsu Province, Nanjing 210009, China.
  • Liu Q; Department of Chronic Communicable Disease, Center for Disease Control and Prevention of Jiangsu Province, Nanjing 210009, China.
  • Lu W; Department of Chronic Communicable Disease, Center for Disease Control and Prevention of Jiangsu Province, Nanjing 210009, China Department of Epidemiology for School of Public Health, Nanjing Medical University, Nanjing 211166, China.
Zhonghua Liu Xing Bing Xue Za Zhi ; 44(3): 470-476, 2023 Mar 10.
Article em Zh | MEDLINE | ID: mdl-36942344

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose / Tuberculose Resistente a Múltiplos Medicamentos / Tuberculose Latente Tipo de estudo: Guideline Limite: Humans País/Região como assunto: Asia Idioma: Zh Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose / Tuberculose Resistente a Múltiplos Medicamentos / Tuberculose Latente Tipo de estudo: Guideline Limite: Humans País/Região como assunto: Asia Idioma: Zh Ano de publicação: 2023 Tipo de documento: Article